Similar results were reported by the study of Kothny et al. [12], in which VIL-INS or a combination of vildagliptin and metformin with insulin (VIL-MET-INS) significantly reduced the HbA1c level with low risk of hypoglycemia and weight gain in patients with T2DM. Here, INS is linked to type 2 diabetes mellitus.